Health Care/Hospital
Gannex Received U.S. FDA Fast Track Designation for Its NASH Drug Candidate ASC42，an FXR Agonist
SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) and fully dedicated to the R&D and commercialization of new drugs in the field of NASH, announced today that it received Fast Track designation from the U.S. Food and Drug Administration (F...
2020-12-14 08:30
3472
Global Healthcare Service Robots Market will grow to US$ 3091.18 Mn by 2028 at a CAGR of 15.7% over the forecast period - says Absolute Markets Insights
PUNE, India, Dec. 14, 2020 /PRNewswire/ --
* Global healthcare service robots market
2020-12-14 08:00
2499
Seegene's aggregated sales surpass KRW 1 tril. this year and plans on expanding annual production capacity to KRW 5 tril. in 2021
SEOUL, South Korea, Dec. 13, 2020 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnosis, Seegene Inc. (KQ096530), announced Monday that its aggregated sales this year have already surpassed theKRW 1 trillion mark, up nearly 10 times its previous annual sales of K...
2020-12-14 07:30
5044
Kintor Proxalutamide's COVID-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates
SUZHOU, China, Dec. 12, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide's clinical trial for the treatment of COVID-19. Proxalutamide is a new androgen receptor (AR) antagonist developed in by Kintor Pharmaceutica...
2020-12-12 11:02
12786
Secret behind speedy construction of Huoshenshan and Leishenshan hospitals
BEIJING, Dec. 11, 2020 /PRNewswire/ -- A news report by China.org.cn: At the beginning of 2020, billions of netizens at home and abroad joined online and cheered for the speedy construction of two hospitals inWuhan. It was during the Spring Festival when CSCEC built two emergency hospitals – Huo...
2020-12-12 00:00
4045
PharmaBlock Enters Strategic Partnership with Ascentage Pharma
NANJING, China, Dec. 11, 2020 /PRNewswire/ -- PharmaBlock Sciences (Nanjing), Inc. (300725.SZ), a leading innovative chemistry product and service provider throughout the pharmaceutical R&D process, announced the signing of a strategic partnership agreement with Ascentage Pharma (6855.HK), a glob...
2020-12-11 21:00
6902
BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Not intended for US-, Canada- and UK-based media DARMSTADT, Germany and NEW YORK, Dec. 11, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion rec...
2020-12-11 21:00
6682
Kintor Pharmaceutical Announces Preliminary Results from the Proxalutamide's Clinical Trial
SUZHOU, China, Dec. 11, 2020 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to update the preliminary analysis of the Proxalutamide's clinical trial for COVID-19. Proxalutamide is a new androgen receptor (AR) antagonist developed in by Kintor Pharmaceutical and is currentl...
2020-12-11 19:44
9863
BookDoc won the Pfizer and Alibaba jointly organized competition - Healthcare Fintech Alliance (HFA) Innovation Challenge, Asia
KUALA LUMPUR, Malaysia, Dec. 11, 2020 /PRNewswire/ -- BookDoc, a home-grown Malaysian health-tech company (with presence in 5 countries and 20 cities, MY, SG, HK, TH, IND), has again been recognised as the top health-tech company acrossAsia, battling over 100 other participants across Asia. The c...
2020-12-11 17:38
4480
Innovent Announces First Patient Dosed in Phase 2 Pivotal Trial of IBI310 (CTLA-4) combined with TYVYT® (sintilimab injection) for the treatment of second-line or above Advanced Cervical Cancer
SAN FRANCISCO and SUZHOU, China, Dec. 11, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2020-12-11 09:02
7917
Antengene Announces Acceptance of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM
SHANGHAI and HONG KONG, Dec. 11, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...
2020-12-11 08:00
5334
European Union Intellectual Property Office Revokes Counterfeiter's Fake AQUAGOLD® Design Registration and Orders Payment to Aquavit of All Legal Fees and Costs
NEW YORK, Dec. 11, 2020 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") received a decision from the European Union Intellectual Property Office (EUIPO) today that it has revoked the counterfeiter U-BioMed's falsely registered AQUAGOLD® design, originally created and owned by Aquavit. ...
2020-12-11 03:10
3581
Global Biosimilars Market Poised to Grow at Chart-topping Levels with a CAGR of 17.3%, Reaching $79.2 Billion by 2026
With the third wave of biosimilars in the spotlight during the forecast period, revenues from the sensory organs market will dominate growth, finds Frost & Sullivan SANTA CLARA, Calif., Dec. 11, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Access to New Therapy Areas to Drive Major Gr...
2020-12-11 03:00
1845
DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor and positive impact of reference anti-HER2 treatment on overall survival
Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020...
2020-12-10 22:19
5009
INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China
PLYMOUTH MEETING, Pa. and SUZHOU, China, Dec. 10, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou Co., Ltd. ("...
2020-12-10 21:00
6235
MicroPort CRM initiates a clinical trial for breakthrough innovative left ventricular lead Axone(TM)
PARIS, Dec. 10, 2020 /PRNewswire/ -- MicroPort Cardio Rhythm Management (CRM) has announced the first enrollment in the Astral-4LV clinical trial[1] to evaluate the safety and efficiency of Axone™, a breakthrough innovative quadripolar left ventricular lead. Axone™ is designed for use in heart fa...
2020-12-10 19:23
1604
Chinese and European Media Carry Out Multilateral Cooperation to Achieve Win-Win Results
BEIJING, Dec. 10, 2020 /PRNewswire/ -- A statement on strengthening media cooperation issued by China Media Group (CMG) and its European media partners, calling on the Chinese and European media to fulfill their responsibilities as public information disseminators and jointly help the internat...
2020-12-10 17:30
1707
Cigna Study Shows Hong Kong's Overall Well-being Index Continues to Drop during the COVID-19 Pandemic
HONG KONG, Dec. 10, 2020 /PRNewswire/ -- Cigna Hong Kong today released the Hong Kong findings of the latest edition of its Cigna COVID-19 Global Impact Study. As part of Cigna's annual 360 Well-Being Survey, this research is the third in a series of studies to better understand the impact of...
2020-12-10 16:04
3065
ReCor Medical Announces Positive Results in RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise™ Ultrasound Renal Denervation System
PALO ALTO, Calif., Dec. 10, 2020 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise™ Ultrasound Renal Denervation System (the "Paradise System") demonstrated positive results in the RADIANCE-HTN TRIO ("TRIO") study...
2020-12-10 16:01
1715
Nippon Express Korea Receives ISO 13485 Certification of Compliance with International Standard for Medical Device Quality Management Systems
TOKYO, Dec. 10, 2020 /PRNewswire/ -- Nippon Express Korea Co., Ltd. (hereinafter "NE Korea"), a local subsidiary of Nippon Express Co., Ltd., last month obtained ISO 13485 certification of compliance with the ISO standard for medical device quality management systems at its business location at I...
2020-12-10 15:00
1575
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15
Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 311 media titles]
2025-12-04 16:00
Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
4477
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
3650
MALAYSIA REMAINS COMMITTED TO ACCELERATE TRANSFORMATIVE SOLUTIONS FOR A SUSTAINABLE AND INCLUSIVE FUTURE
2025-12-06 00:41
3632
PAVS Achieves 18,037% YoY Revenue Increase in 2025 Interim Results
2025-12-05 21:45
3439